Investigating the Mechanism of Banxia Xiexin Decoction in Treating Gastritis and Diabetes Mellitus through Network Pharmacology and Molecular Docking Analysis

Title:Investigating the Mechanism of Banxia Xiexin Decoction in Treating Gastritis and Diabetes Mellitus through Network Pharmacology and Molecular Docking Analysis

Volume: 19 Issue: 7

Author(s): Yikuan Du, Xianhong Chi, Qianwen Chen, Yue Xiao, Zhendong Ma, Zhenjie Wang, Zhuoming Guo, Peng Chen, Zilin Chen, Mengting Zhang, Jinyan Guo, Yuqi Zhou and Chun Yang*

Affiliation:

• Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medica University, Dongguan, 523808, People's Republic of China
• Dongguan Key Laboratory of Chronic lnflammatory Diseases, The First Dongguan Affiliated Hospital. Guangdong Medical University, Dongguan, 523808, People's Republic of China

Keywords: Banxia Xiexin Decoction, gastritis, diabetes mellitus, network pharmacology, molecular docking, same treatment for different diseases.

Abstract:

Background: Banxia Xiexin Decoction (BXD), a complex prescription in Traditional Chinese Medicine (TCM), clinically acts as a treatment for gastritis and diabetes while its mechanism of treatment remains unknown.

Objection: This study aimed to explore the common mechanism of BXD in treating gastritis and diabetes based on network pharmacology and molecular docking technology.

Methods: The seven Chinese herbal components and drug targets were collected from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) for gastritis and diabetes using GeneCards, DisGeNET, Comparative Toxicogenomics Database (CTD), and Online Mendelian Inheritance in Man (OMIM) databases. Common drug and disease targets were imported into the STRING data platform for protein-protein interaction (PPI) analysis, and Cytoscape 3.7.2 software for network topology analysis, and core targets were filtered.

Results: There were 124 components, 249 targets, 449 targets for gastritis, and 4005 targets for diabetes. After mapping, 83 BXD targets for gastritis and diabetes were obtained, and the targets with high correlation were STAT 3, JUN, TNF, IL-6, etc. More relevant targets were involved in the cancer pathway, AGE-RAGE signaling pathway of diabetic complications, fluid shear stress, and atherosclerosis pathway.

Conclusion: This study preliminarily reveals that BXD may play a role in the treatment of gastritis and diabetes mellitus through multi-components, multi-targets, and multi-pathways, and proposes some potential "component-target-pathway" hypotheses in light of previous reports.

Cite this article as:

Du Yikuan, Chi Xianhong, Chen Qianwen, Xiao Yue, Ma Zhendong, Wang Zhenjie, Guo Zhuoming, Chen Peng, Chen Zilin, Zhang Mengting, Guo Jinyan, Zhou Yuqi and Yang Chun*, Investigating the Mechanism of Banxia Xiexin Decoction in Treating Gastritis and Diabetes Mellitus through Network Pharmacology and Molecular Docking Analysis, Current Drug Therapy 2024; 19 (7) . https://dx.doi.org/10.2174/0115748855287070240409061220